bioMérieux Sweden AB
556266-0653ActiveWorld leader developing in vitro diagnostics for health and safety.
Oversigt
- 20–49
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 1985
- Grundlagt
Nøglebeslutningstagere
Pierre Boulud
Chief Executive Officer
Charles K. Cooper
Executive Vice President, Chief Medical Officer
Audrey Dauvet
Executive Vice President, Legal, Corporate Integrity & Public Affairs
Bénédicte Blot
Vice President, HSE
+13 flere kontakter i Funnelfeedr
Beskrivelse
bioMérieux is a family-owned company recognized globally as a world leader in the field of in vitro diagnostics (IVD). Their core mission is dedicated to improving public health worldwide through pioneering diagnostic solutions. The company specializes in clinical applications, providing healthcare...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Partihandel med mät- och precisionsinstrument
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556266065301
Beslutningstagere
17 kontakter i FunnelfeedrPierre Boulud
Chief Executive Officer
Charles K. Cooper
Executive Vice President, Chief Medical Officer
Audrey Dauvet
Executive Vice President, Legal, Corporate Integrity & Public Affairs
Bénédicte Blot
Vice President, HSE
Valérie Leyldé
Executive Vice President, Human Resources, Communication & CSR
Yasha Mitrotti
Executive Vice President, Industrial Applications
Alexandre Mérieux
Chairman of the Board of Directors
Alain Mérieux
Founding President
Sylvain Orenga
Director representing employees
Jennifer Zinn
Executive Vice President, Clinical Operations
Céline Roger-Dalbert
Executive Vice President, Research & Development
Pierre Charbonnier
Executive Vice President, Global Quality, Manufacturing and Supply Chain
Guillaume Bouhours
Chief Financial Officer, Executive Vice President, Purchasing and Information Systems
Andre kontakter
Olivier Rescanière
Media Contact
Romain Duchez
Media Contact
Kevin L. Williams
Technical Expert
Christian Faderl
Technical Expert
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrLumiraDx Aktiebolag
3 medarbejdereGlobal leader providing advanced in-vitro diagnostic solutions at the point of need.
CERUS EUROPE BV
1–4 medarbejdereCerus Corporation develops vital technologies to secure the global blood supply.
Gradientech AB
20–49 medarbejdereDeveloping ultra-rapid diagnostic systems for antibiotic susceptibility testing.
Sangair AB
3 medarbejdereDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Amferia AB
5–9 medarbejdereDeveloping peptide hydrogel technology to combat bacterial infections safely.
Udforsk mere
Spørgsmål om bioMérieux Sweden AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo